Olof Strandberg

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz et al. · JAMA · 2020 · 1.4K citations · Full text

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

Sebastian Palmqvist, Michael Schöll, Olof Strandberg et al. · Nature Communications · 2017 · 887 citations · Full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease

Jacob W. Vogel, Yasser Iturria‐Medina, Olof Strandberg et al. · Nature Communications · 2020 · 509 citations · Full text

Neurochemical Biomarkers, Synaptic Signaling, Social Sciences +21